ATE424186T1 - Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff - Google Patents
Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoffInfo
- Publication number
- ATE424186T1 ATE424186T1 AT02806511T AT02806511T ATE424186T1 AT E424186 T1 ATE424186 T1 AT E424186T1 AT 02806511 T AT02806511 T AT 02806511T AT 02806511 T AT02806511 T AT 02806511T AT E424186 T1 ATE424186 T1 AT E424186T1
- Authority
- AT
- Austria
- Prior art keywords
- polyethylene glycol
- compositions containing
- excipient
- aerosol compositions
- functionalized polyethylene
- Prior art date
Links
- 239000002202 Polyethylene glycol Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000000546 pharmaceutical excipient Substances 0.000 title abstract 3
- 229920001223 polyethylene glycol Polymers 0.000 title abstract 3
- 239000000443 aerosol Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34278701P | 2001-12-21 | 2001-12-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424186T1 true ATE424186T1 (de) | 2009-03-15 |
Family
ID=23343270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02806511T ATE424186T1 (de) | 2001-12-21 | 2002-12-20 | Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7718162B2 (enExample) |
| EP (1) | EP1458357B1 (enExample) |
| JP (1) | JP4959919B2 (enExample) |
| AT (1) | ATE424186T1 (enExample) |
| AU (1) | AU2002367032B8 (enExample) |
| CA (1) | CA2470520A1 (enExample) |
| DE (1) | DE60231428D1 (enExample) |
| WO (1) | WO2003059317A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003059331A2 (en) * | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| US20030147814A1 (en) * | 2001-12-21 | 2003-08-07 | 3M Innovative Properties Company | Medicinal aerosol formulations comprising ion pair complexes |
| DE60231428D1 (de) | 2001-12-21 | 2009-04-16 | 3M Innovative Properties Co | Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff |
| GB0614621D0 (en) | 2006-07-24 | 2006-08-30 | 3M Innovative Properties Co | Metered dose dispensers |
| GB0620700D0 (en) | 2006-10-19 | 2006-11-29 | 3M Innovative Properties Co | Metered dose valves and dispensers |
| NZ599344A (en) * | 2009-09-25 | 2015-02-27 | Reddy’S Lab Ltd Dr | Formulations comprising triptan compounds |
| US11337962B2 (en) | 2009-09-25 | 2022-05-24 | Upsher-Smith Laboratories, Llc | Formulations comprising triptan compounds |
| WO2011084316A2 (en) | 2009-12-16 | 2011-07-14 | 3M Innovative Properties Company | Formulations and methods for controlling mdi particle size delivery |
| GB201118188D0 (en) | 2011-10-21 | 2011-12-07 | 3M Innovative Properties Co | Manufacture of medicinal aerosol canisters |
| GB201210580D0 (en) | 2012-06-14 | 2012-08-01 | 3M Innovative Properties Co | Metered dose dispensing valve |
| GB201221063D0 (en) | 2012-11-23 | 2013-01-09 | 3M Innovative Properties Co | Metered dose dispensing valve |
| WO2019007750A1 (en) | 2017-07-07 | 2019-01-10 | Basf Se | ALCOXYLATED ESTERAMINES AND THEIR SALTS |
| CN117042803A (zh) * | 2021-12-02 | 2023-11-10 | 丽泽润有限公司 | 具有多功能应用的天然赋形剂及其制备方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1163028B (de) * | 1960-03-09 | 1964-02-13 | Hoechst Ag | Verfahren zur Polymerisation von Vinylchlorid |
| ATE60226T1 (de) * | 1986-03-10 | 1991-02-15 | Kurt Burghart | Pharmazeutikum sowie verfahren zu seiner herstellung. |
| AU597049B2 (en) * | 1986-03-10 | 1990-05-24 | Kurt Burghart | Pharmaceutical preparation containing nifedipine |
| US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| US5342940A (en) * | 1989-05-27 | 1994-08-30 | Sumitomo Pharmaceuticals Company, Limited | Polyethylene glycol derivatives, process for preparing the same |
| WO1992000061A1 (en) * | 1990-06-29 | 1992-01-09 | Fisons Plc | Pressurised aerosol compositions |
| WO1994008599A1 (en) * | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
| JP3009924B2 (ja) | 1992-12-09 | 2000-02-14 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 安定化医用エアーゾル溶液製剤 |
| CA2156408C (en) * | 1993-03-17 | 2005-02-15 | Daniel C. Duan | Aerosol formulation containing a polyester dispersing aid |
| JPH08507792A (ja) * | 1993-03-17 | 1996-08-20 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物 |
| US5492688A (en) * | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
| DK0731688T3 (da) * | 1993-12-02 | 2003-06-23 | Abbott Lab | Aerosol-lægemiddelformuleringer til anvendelse med CFC-frie drivmidler |
| US5508023A (en) * | 1994-04-11 | 1996-04-16 | The Center For Innovative Technology | Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
| US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| US6517860B1 (en) * | 1996-12-31 | 2003-02-11 | Quadrant Holdings Cambridge, Ltd. | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
| US6126919A (en) * | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| US6218353B1 (en) * | 1997-08-27 | 2001-04-17 | Micell Technologies, Inc. | Solid particulate propellant systems and aerosol containers employing the same |
| US6136294C1 (en) * | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
| DE69904498T2 (de) * | 1998-10-27 | 2003-04-24 | Alcon Laboratories, Inc. | Konservierungsmittel für lokale pharmazeutische zubereitungen enthaltend eine fettsäure/aminosäure enthaltende seife |
| US6258857B1 (en) * | 1999-02-04 | 2001-07-10 | Kyowa Industrial Co., Ltd. | Internal liquid composition contained as internal liquid in a releasing container and releasing container product |
| GB0016876D0 (en) | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Novel formulation |
| JP2004509159A (ja) | 2000-09-22 | 2004-03-25 | グラクソ グループ リミテッド | 新規なアルカン酸誘導体 |
| TR200400295T2 (tr) * | 2001-05-21 | 2005-04-21 | Nektar Therapeutics | Kimyasal olarak modifiye edilmiş ensülin'in akçiğer yoluyla verilmesi |
| GB0125127D0 (en) | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Compounds |
| DE60231428D1 (de) | 2001-12-21 | 2009-04-16 | 3M Innovative Properties Co | Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff |
| WO2003059331A2 (en) * | 2001-12-21 | 2003-07-24 | 3M Innovative Properties Company | Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
-
2002
- 2002-12-20 DE DE60231428T patent/DE60231428D1/de not_active Expired - Lifetime
- 2002-12-20 EP EP02806511A patent/EP1458357B1/en not_active Expired - Lifetime
- 2002-12-20 US US10/327,200 patent/US7718162B2/en not_active Expired - Fee Related
- 2002-12-20 AU AU2002367032A patent/AU2002367032B8/en not_active Ceased
- 2002-12-20 JP JP2003559480A patent/JP4959919B2/ja not_active Expired - Fee Related
- 2002-12-20 AT AT02806511T patent/ATE424186T1/de not_active IP Right Cessation
- 2002-12-20 CA CA002470520A patent/CA2470520A1/en not_active Abandoned
- 2002-12-20 WO PCT/US2002/041299 patent/WO2003059317A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002367032B8 (en) | 2008-10-23 |
| DE60231428D1 (de) | 2009-04-16 |
| CA2470520A1 (en) | 2003-07-24 |
| EP1458357B1 (en) | 2009-03-04 |
| EP1458357A2 (en) | 2004-09-22 |
| US7718162B2 (en) | 2010-05-18 |
| JP2006502086A (ja) | 2006-01-19 |
| WO2003059317A2 (en) | 2003-07-24 |
| US20030152521A1 (en) | 2003-08-14 |
| JP4959919B2 (ja) | 2012-06-27 |
| WO2003059317A3 (en) | 2003-11-20 |
| AU2002367032B2 (en) | 2008-09-25 |
| AU2002367032A1 (en) | 2003-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE424186T1 (de) | Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff | |
| EA200401006A1 (ru) | Аэрозольные препараты для внутрилёгочного введения лекарств с получением системного действия | |
| BR9909394A (pt) | Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado | |
| BR0214254A (pt) | Pó filmogênio micronizado e composição farmacêutica, cosmética ou neutracêutica | |
| HUP9800641A2 (hu) | Inhaláló berendezés beklometaszon-dipropionát adagolására mért dózisban | |
| ATE287699T1 (de) | Pharmazeutische aerosolzusammensetzungen | |
| ATE336268T1 (de) | Medizinische aerosolzubereitung | |
| BR0215380A (pt) | Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo | |
| ATE271383T1 (de) | Pulverformulierung zur inhalation | |
| SE0002643L (sv) | Inhalationsberedningar innehållande mikropartiklar | |
| BG105189A (bg) | Капсула от две части за пълнене с фармацевтични препарати за прахови инхалатори | |
| FI956228A0 (fi) | Sisäänhengitykseen tarkoitettuja koostumuksia | |
| HUP9802454A2 (hu) | Inhalálókészülék | |
| CA2381329A1 (en) | Medicaments | |
| EP1757269A3 (en) | Pulmonary formulation comprising silicon particles | |
| HUP9802391A2 (hu) | Inhaláló berendezés szalmeterol adagolására mért dózisban | |
| ATE233544T1 (de) | Aerosole als darreichungsform mit cfc-freiem treibmittel | |
| ATE364381T1 (de) | Formulierungen zur verwendung in inhalationsvorrichtungen | |
| ATE321537T1 (de) | Pharmazeutische zubereitung enthaltend doxazosin | |
| ATE420630T1 (de) | Pulverzubereitungen und verfahren zu ihrer herstellung | |
| ATE265408T1 (de) | Pulverisiertes mannit und verfahren zu deren herstellung | |
| WO2003075977A3 (en) | Agglomerated particles for aerosol drug delivery | |
| ATE406152T1 (de) | Medizinische aerosolzusammensetzungen mit einer eine amid- und/oder estergruppe enthaltenden exzipientenverbindung | |
| AP2000001837A0 (en) | Pharmaceutical compositions containing micronized bicyclic drugs. | |
| WO2004062651A8 (en) | Pharmaceutical aerosol composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |